ADVFN Logo ADVFN

Wir konnten keine Ergebnisse für:
Stelle sicher, dass deine Schreibweise korrekt ist oder versuche deine Suche zu erweitern.

Trends

Toplisten

Es scheint, dass du nicht eingeloggt bist.
Klicke auf den Button unten, um dich einzuloggen und deine zuletzt angesehenen Aktien zu sehen.

Registrieren

Bereits Mitglied? Einloggen

Pepperstone

Jetzt Handeln

Pepperstone
Marktdaten
News
Werkzeuge
Märkte
Entdecken

Hot Features

Follow Feed

Vernetzen Sie sich mit Händlern und Investoren in unserer Follow-Feed-Community.

Optionen-Flow

Erkunden Sie umfassende Optionsdaten und nutzen Sie erweiterte Filter mit Options Flow.

Watchlist

Organisieren und überwachen Sie Ihre Aktien- und Vermögensbeobachtungsliste mit dem Monitor.
Anmelden Premium IconPremium Help Menu
DAX
18.704,42
-0,11%
S&P 500
5.303,27
0,12%
Dow Jones
40.003,59
0,34%
Euro vs US Dollar
1,08703
0,03%
Bitcoin
66.879,60
2,51%
Registration Strip Icon for alerts Registrieren Sie sich für Echtzeit-Benachrichtigungen, benutzerdefinierte Portfolios und Marktbewegungen.
Registrieren
  1. Startseite
  2. Investieren
  3. Aktien
  4. USA
  5. NASDAQ
  6. Mereo BioPharma Group PLC (MREO)

  7. Mereo BioPharma Group PLC (MREO) News

MREO

Mereo BioPharma (MREO)

Mereo BioPharma Group PLC
Von:
Sortieren nach:
 Showing the most relevant articles for your search:NASDAQ:MREO
DatumZeitQuelleÜberschriftSymbolFirma
15/05/202422h49Edgar (US Regulatory)Form S-3 - Registration statement under Securities Act of 1933NASDAQ:MREOMereo BioPharma Group PLC
15/05/202422h19Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:MREOMereo BioPharma Group PLC
15/05/202422h06Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:MREOMereo BioPharma Group PLC
15/05/202422h01GlobeNewswire Inc.Mereo BioPharma Reports First Quarter 2024 Financial Results and Provides Corporate UpdateNASDAQ:MREOMereo BioPharma Group PLC
03/04/202413h30GlobeNewswire Inc.Mereo BioPharma to Participate in Fireside Chat at the 23rd Annual Needham Virtual Healthcare ConferenceNASDAQ:MREOMereo BioPharma Group PLC
27/03/202421h01GlobeNewswire Inc.Mereo BioPharma Reports Full Year 2023 Financial Results and Provides Corporate UpdateNASDAQ:MREOMereo BioPharma Group PLC
05/03/202413h30GlobeNewswire Inc.Mereo BioPharma to Participate in Fireside Chat at the Leerink Partners Global Biopharma ConferenceNASDAQ:MREOMereo BioPharma Group PLC
09/02/202422h15Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:MREOMereo BioPharma Group PLC
09/02/202422h15Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:MREOMereo BioPharma Group PLC
09/02/202422h15Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:MREOMereo BioPharma Group PLC
09/02/202422h15Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:MREOMereo BioPharma Group PLC
06/02/202422h15Edgar (US Regulatory)Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]NASDAQ:MREOMereo BioPharma Group PLC
26/01/202422h15Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:MREOMereo BioPharma Group PLC
26/01/202422h15Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:MREOMereo BioPharma Group PLC
23/01/202422h16Edgar (US Regulatory)Form S-8 - Securities to be offered to employees in employee benefit plansNASDAQ:MREOMereo BioPharma Group PLC
08/01/202413h08Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:MREOMereo BioPharma Group PLC
08/01/202413h00GlobeNewswire Inc.Mereo BioPharma Provides Update on Pipeline Progress and Corporate DevelopmentsNASDAQ:MREOMereo BioPharma Group PLC
02/01/202422h20Edgar (US Regulatory)Form 3 - Initial statement of beneficial ownership of securitiesNASDAQ:MREOMereo BioPharma Group PLC
02/01/202422h17Edgar (US Regulatory)Form 3 - Initial statement of beneficial ownership of securitiesNASDAQ:MREOMereo BioPharma Group PLC
02/01/202422h16Edgar (US Regulatory)Form 3 - Initial statement of beneficial ownership of securitiesNASDAQ:MREOMereo BioPharma Group PLC
02/01/202422h15Edgar (US Regulatory)Form 3 - Initial statement of beneficial ownership of securitiesNASDAQ:MREOMereo BioPharma Group PLC
02/01/202422h15Edgar (US Regulatory)Form 3 - Initial statement of beneficial ownership of securitiesNASDAQ:MREOMereo BioPharma Group PLC
02/01/202422h15Edgar (US Regulatory)Form 3 - Initial statement of beneficial ownership of securitiesNASDAQ:MREOMereo BioPharma Group PLC
02/01/202422h15Edgar (US Regulatory)Form 3 - Initial statement of beneficial ownership of securitiesNASDAQ:MREOMereo BioPharma Group PLC
18/12/202322h16Edgar (US Regulatory)Form 8-A12B/A - Registration of securities [Section 12(b)]: [Amend]NASDAQ:MREOMereo BioPharma Group PLC
18/12/202322h10Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:MREOMereo BioPharma Group PLC
29/11/202322h15Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:MREOMereo BioPharma Group PLC
16/11/202313h01Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:MREOMereo BioPharma Group PLC
23/10/202322h08Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:MREOMereo BioPharma Group PLC
23/10/202322h01GlobeNewswire Inc.Mereo BioPharma Reports on Recent Program Developments and Provides Financial UpdateNASDAQ:MREOMereo BioPharma Group PLC
 Showing the most relevant articles for your search:NASDAQ:MREO

Kürzlich von Ihnen besucht

LSE
0LAI
Summit Materials
Delayed Upgrade Clock
ADVFN Logo

Deutschland
Unternehmen
Geschäft
Popular
App herunterladen

Support: +44 (0) 203 8794 460 | support@advfn.de

Durch das Benutzen des ADVFN Angebotes akzeptieren Sie folgende Allgemeine Geschäftsbedingungen

© 2024 ADVFN PLC - Alle Rechte vorbehalten